Kurma Partners Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 13
Professionals
  • Investments
  • 94
  • Portfolio
  • 43
  • Exits
  • 22
Exits

Kurma Partners General Information

Description

Founded in 2009, Kurma Partners is a venture capital firm based in Paris, France. The firm focuses on the healthcare and biotechnology industries. The firm seeks to invest from pre-seed to growth capital, notably through Kurma Bio fund I, II, and Kurma Diagnostics, as well as via strategic partnerships with prestigious European research and medical institutions.

Contact Information

Year Founded
2009
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
  • 24, Rue Royale
  • 5th Floor
  • 75008 Paris
  • France
+33 01 00 00 00 00

Kurma Partners Investments (94)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
MedLumics 10-Feb-2021 Later Stage VC 000.00 Diagnostic Equipment Generating Revenue 00000 0000000 00
00 0000000 13-Jan-2021 00000 00000 00000 Drug Discovery Clinical Trials - Phase 3 0000000 000000
000000000 00000000 25-Nov-2020 0000 00000 Drug Discovery Generating Revenue 00000 0000000 00
000000 18-Nov-2020 0000 00000 00.000 Other Healthcare Technology Systems Generating Revenue 00000000 0000000
00000000 000000000 12-Nov-2020 00000 00000 0000 Drug Discovery Clinical Trials - General 00000 0000000 00
00000000 000000000 02-Nov-2020 0000 00000 00.00 Drug Discovery Startup 0000000 000000
0000000 0000000000 15-Sep-2020 00000 00000 0000 Drug Discovery Clinical Trials - Phase 1 0é00 0000000 00.0
0000000 15-Aug-2020 00000 00000 000.00 Drug Discovery Generating Revenue 0000000 000000 00.0
DNA Script 29-Jul-2020 Later Stage VC 000.00 Biotechnology Generating Revenue 00000000 0000000
Vico Therapeutics 15-Jul-2020 Early Stage VC 000.00 Drug Discovery Generating Revenue 0é00 0000000 00.0
You’re viewing 10 of 94 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Kurma Partners Exits (22)

Company Name Exit Date Exit Type Exit Size
Pharvaris 05-Feb-2021 IPO 00000
00000000 000000000 22-Jan-2020 000000000000000000
0000000 000000 24-Sep-2018 000 000.00
00000 000000000000 01-Sep-2018 000000000000000000
0000-00 19-Apr-2018 000000000000000000 00000
000000000 21-Nov-2017 000 000.00
0000 000000000000 07-Jul-2017 000000000 00000000
0000000 20-Sep-2016 000 00 00000000
Safe Orthopaedics 05-Feb-2015 IPO 0000
Genticel 03-Apr-2014 IPO 000.00
You’re viewing 10 of 22 exits. Get the full list »

Kurma Partners Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Kurma Partners Team (29)

Name Title Deals Funds Boards Office
Sylvain Cascarino Chief Financial Officer & Partner Paris, France
Rémi Droller Ph.D Managing Partner 00 0 0 Paris, France
Vanessa Malier Managing Partner 00 0 0 Paris, France
Alain Munoz Ph.D Venture Partner 0 0 0 Paris, France
Alain Horvais Ph.D Partner 0 0 0 Paris, France
You’re viewing 5 of 29 team members. Get the full list »

Kurma Partners Co-Investors (118)

Name With Exits Lead Partner Series Industry
Idinvest Partners 24 0 Series chart Industry bar
Bpifrance 0 00 Series chart Industry bar
Life Sciences Partners 0 0 Series chart Industry bar
Partech 0 0 Series chart Industry bar
Pontifax Venture Capital 0 0 Series chart Industry bar
You’re viewing 5 of 118 co-investors. Get the full list »